4//SEC Filing
Backenroth Samuel 4
Accession 0001104659-20-056066
CIK 0001173281other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 12:28 PM ET
Size
12.3 KB
Accession
0001104659-20-056066
Insider Transaction Report
Form 4
Backenroth Samuel
CEO & VP of Bus. Development
Transactions
- Purchase
Common Stock
2020-04-30$6.00/sh+1,000$6,000→ 11,630 total
Footnotes (1)
- [F1]The power of attorney under which this form was signed is on file with the Commission.
Issuer
NeuBase Therapeutics, Inc.
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001579887
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 12:28 PM ET
- Size
- 12.3 KB